Copyright Reports & Markets. All rights reserved.

Global Targeted Protein Degradation Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Targeted Protein Degradation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Oral
    • 1.2.3 Intravenous
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Targeted Protein Degradation Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Research Institute
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Targeted Protein Degradation Market Perspective (2016-2027)
  • 2.2 Targeted Protein Degradation Growth Trends by Regions
    • 2.2.1 Targeted Protein Degradation Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Targeted Protein Degradation Historic Market Share by Regions (2016-2021)
    • 2.2.3 Targeted Protein Degradation Forecasted Market Size by Regions (2022-2027)
  • 2.3 Targeted Protein Degradation Industry Dynamic
    • 2.3.1 Targeted Protein Degradation Market Trends
    • 2.3.2 Targeted Protein Degradation Market Drivers
    • 2.3.3 Targeted Protein Degradation Market Challenges
    • 2.3.4 Targeted Protein Degradation Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Targeted Protein Degradation Players by Revenue
    • 3.1.1 Global Top Targeted Protein Degradation Players by Revenue (2016-2021)
    • 3.1.2 Global Targeted Protein Degradation Revenue Market Share by Players (2016-2021)
  • 3.2 Global Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Targeted Protein Degradation Revenue
  • 3.4 Global Targeted Protein Degradation Market Concentration Ratio
    • 3.4.1 Global Targeted Protein Degradation Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Revenue in 2020
  • 3.5 Targeted Protein Degradation Key Players Head office and Area Served
  • 3.6 Key Players Targeted Protein Degradation Product Solution and Service
  • 3.7 Date of Enter into Targeted Protein Degradation Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Protein Degradation Breakdown Data by Type

  • 4.1 Global Targeted Protein Degradation Historic Market Size by Type (2016-2021)
  • 4.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2022-2027)

5 Targeted Protein Degradation Breakdown Data by Application

  • 5.1 Global Targeted Protein Degradation Historic Market Size by Application (2016-2021)
  • 5.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Targeted Protein Degradation Market Size (2016-2027)
  • 6.2 North America Targeted Protein Degradation Market Size by Type
    • 6.2.1 North America Targeted Protein Degradation Market Size by Type (2016-2021)
    • 6.2.2 North America Targeted Protein Degradation Market Size by Type (2022-2027)
    • 6.2.3 North America Targeted Protein Degradation Market Size by Type (2016-2027)
  • 6.3 North America Targeted Protein Degradation Market Size by Application
    • 6.3.1 North America Targeted Protein Degradation Market Size by Application (2016-2021)
    • 6.3.2 North America Targeted Protein Degradation Market Size by Application (2022-2027)
    • 6.3.3 North America Targeted Protein Degradation Market Size by Application (2016-2027)
  • 6.4 North America Targeted Protein Degradation Market Size by Country
    • 6.4.1 North America Targeted Protein Degradation Market Size by Country (2016-2021)
    • 6.4.2 North America Targeted Protein Degradation Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Targeted Protein Degradation Market Size (2016-2027)
  • 7.2 Europe Targeted Protein Degradation Market Size by Type
    • 7.2.1 Europe Targeted Protein Degradation Market Size by Type (2016-2021)
    • 7.2.2 Europe Targeted Protein Degradation Market Size by Type (2022-2027)
    • 7.2.3 Europe Targeted Protein Degradation Market Size by Type (2016-2027)
  • 7.3 Europe Targeted Protein Degradation Market Size by Application
    • 7.3.1 Europe Targeted Protein Degradation Market Size by Application (2016-2021)
    • 7.3.2 Europe Targeted Protein Degradation Market Size by Application (2022-2027)
    • 7.3.3 Europe Targeted Protein Degradation Market Size by Application (2016-2027)
  • 7.4 Europe Targeted Protein Degradation Market Size by Country
    • 7.4.1 Europe Targeted Protein Degradation Market Size by Country (2016-2021)
    • 7.4.2 Europe Targeted Protein Degradation Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Targeted Protein Degradation Market Size (2016-2027)
  • 8.2 Asia-Pacific Targeted Protein Degradation Market Size by Type
    • 8.2.1 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Targeted Protein Degradation Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Targeted Protein Degradation Market Size by Application
    • 8.3.1 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Targeted Protein Degradation Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Targeted Protein Degradation Market Size by Region
    • 8.4.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Targeted Protein Degradation Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Targeted Protein Degradation Market Size (2016-2027)
  • 9.2 Latin America Targeted Protein Degradation Market Size by Type
    • 9.2.1 Latin America Targeted Protein Degradation Market Size by Type (2016-2021)
    • 9.2.2 Latin America Targeted Protein Degradation Market Size by Type (2022-2027)
    • 9.2.3 Latin America Targeted Protein Degradation Market Size by Type (2016-2027)
  • 9.3 Latin America Targeted Protein Degradation Market Size by Application
    • 9.3.1 Latin America Targeted Protein Degradation Market Size by Application (2016-2021)
    • 9.3.2 Latin America Targeted Protein Degradation Market Size by Application (2022-2027)
    • 9.3.3 Latin America Targeted Protein Degradation Market Size by Application (2016-2027)
  • 9.4 Latin America Targeted Protein Degradation Market Size by Country
    • 9.4.1 Latin America Targeted Protein Degradation Market Size by Country (2016-2021)
    • 9.4.2 Latin America Targeted Protein Degradation Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Targeted Protein Degradation Market Size (2016-2027)
  • 10.2 Middle East & Africa Targeted Protein Degradation Market Size by Type
    • 10.2.1 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Targeted Protein Degradation Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Targeted Protein Degradation Market Size by Application
    • 10.3.1 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Targeted Protein Degradation Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Targeted Protein Degradation Market Size by Country
    • 10.4.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Targeted Protein Degradation Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 5AM Venture Management LLC
    • 11.1.1 5AM Venture Management LLC Company Details
    • 11.1.2 5AM Venture Management LLC Business Overview
    • 11.1.3 5AM Venture Management LLC Targeted Protein Degradation Introduction
    • 11.1.4 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.1.5 5AM Venture Management LLC Recent Development
  • 11.2 AbbVie Inc
    • 11.2.1 AbbVie Inc Company Details
    • 11.2.2 AbbVie Inc Business Overview
    • 11.2.3 AbbVie Inc Targeted Protein Degradation Introduction
    • 11.2.4 AbbVie Inc Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.2.5 AbbVie Inc Recent Development
  • 11.3 Almac Group
    • 11.3.1 Almac Group Company Details
    • 11.3.2 Almac Group Business Overview
    • 11.3.3 Almac Group Targeted Protein Degradation Introduction
    • 11.3.4 Almac Group Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.3.5 Almac Group Recent Development
  • 11.4 Amgen Inc.
    • 11.4.1 Amgen Inc. Company Details
    • 11.4.2 Amgen Inc. Business Overview
    • 11.4.3 Amgen Inc. Targeted Protein Degradation Introduction
    • 11.4.4 Amgen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.4.5 Amgen Inc. Recent Development
  • 11.5 Bayer AG
    • 11.5.1 Bayer AG Company Details
    • 11.5.2 Bayer AG Business Overview
    • 11.5.3 Bayer AG Targeted Protein Degradation Introduction
    • 11.5.4 Bayer AG Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.5.5 Bayer AG Recent Development
  • 11.6 Biogen Inc.
    • 11.6.1 Biogen Inc. Company Details
    • 11.6.2 Biogen Inc. Business Overview
    • 11.6.3 Biogen Inc. Targeted Protein Degradation Introduction
    • 11.6.4 Biogen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.6.5 Biogen Inc. Recent Development
  • 11.7 C4 Therapeutics
    • 11.7.1 C4 Therapeutics Company Details
    • 11.7.2 C4 Therapeutics Business Overview
    • 11.7.3 C4 Therapeutics Targeted Protein Degradation Introduction
    • 11.7.4 C4 Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.7.5 C4 Therapeutics Recent Development
  • 11.8 Cosmo Bio USA
    • 11.8.1 Cosmo Bio USA Company Details
    • 11.8.2 Cosmo Bio USA Business Overview
    • 11.8.3 Cosmo Bio USA Targeted Protein Degradation Introduction
    • 11.8.4 Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.8.5 Cosmo Bio USA Recent Development
  • 11.9 Covance Inc
    • 11.9.1 Covance Inc Company Details
    • 11.9.2 Covance Inc Business Overview
    • 11.9.3 Covance Inc Targeted Protein Degradation Introduction
    • 11.9.4 Covance Inc Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.9.5 Covance Inc Recent Development
  • 11.10 Eli Lilly and Company
    • 11.10.1 Eli Lilly and Company Company Details
    • 11.10.2 Eli Lilly and Company Business Overview
    • 11.10.3 Eli Lilly and Company Targeted Protein Degradation Introduction
    • 11.10.4 Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.10.5 Eli Lilly and Company Recent Development
  • 11.11 Gilead Sciences, Inc
    • 11.11.1 Gilead Sciences, Inc Company Details
    • 11.11.2 Gilead Sciences, Inc Business Overview
    • 11.11.3 Gilead Sciences, Inc Targeted Protein Degradation Introduction
    • 11.11.4 Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.11.5 Gilead Sciences, Inc Recent Development
  • 11.12 GlaxoSmithKline plc
    • 11.12.1 GlaxoSmithKline plc Company Details
    • 11.12.2 GlaxoSmithKline plc Business Overview
    • 11.12.3 GlaxoSmithKline plc Targeted Protein Degradation Introduction
    • 11.12.4 GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.12.5 GlaxoSmithKline plc Recent Development
  • 11.13 Merck KGaA
    • 11.13.1 Merck KGaA Company Details
    • 11.13.2 Merck KGaA Business Overview
    • 11.13.3 Merck KGaA Targeted Protein Degradation Introduction
    • 11.13.4 Merck KGaA Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.13.5 Merck KGaA Recent Development
  • 11.14 Mission Therapeutics
    • 11.14.1 Mission Therapeutics Company Details
    • 11.14.2 Mission Therapeutics Business Overview
    • 11.14.3 Mission Therapeutics Targeted Protein Degradation Introduction
    • 11.14.4 Mission Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.14.5 Mission Therapeutics Recent Development
  • 11.15 Novartis AG
    • 11.15.1 Novartis AG Company Details
    • 11.15.2 Novartis AG Business Overview
    • 11.15.3 Novartis AG Targeted Protein Degradation Introduction
    • 11.15.4 Novartis AG Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.15.5 Novartis AG Recent Development
  • 11.16 Pfizer Inc
    • 11.16.1 Pfizer Inc Company Details
    • 11.16.2 Pfizer Inc Business Overview
    • 11.16.3 Pfizer Inc Targeted Protein Degradation Introduction
    • 11.16.4 Pfizer Inc Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.16.5 Pfizer Inc Recent Development
  • 11.17 Promega
    • 11.17.1 Promega Company Details
    • 11.17.2 Promega Business Overview
    • 11.17.3 Promega Targeted Protein Degradation Introduction
    • 11.17.4 Promega Revenue in Targeted Protein Degradation Business (2016-2021)
    • 11.17.5 Promega Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Targeted Protein Degradation Scope and Market Size
    Targeted Protein Degradation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Protein Degradation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Oral
    Intravenous
    Others

    Segment by Application
    Hospital
    Research Institute

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    5AM Venture Management LLC
    AbbVie Inc
    Almac Group
    Amgen Inc.
    Bayer AG
    Biogen Inc.
    C4 Therapeutics
    Cosmo Bio USA
    Covance Inc
    Eli Lilly and Company
    Gilead Sciences, Inc
    GlaxoSmithKline plc
    Merck KGaA
    Mission Therapeutics
    Novartis AG
    Pfizer Inc
    Promega

    Buy now